Data / Form D filings / Gregor Diagnostics, Inc.
Gregor Diagnostics, Inc.: Form D filings
Gregor Diagnostics, Inc., a biotechnology company in Dallas, TX, filed 6 Form D notices with the SEC between 2018 and 2025. The latest, on November 4, 2025, reports $242,034 sold of a $250,000 offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5910 N. Central Expressway, Suite 1400, Dallas, TX, 75206
- Phone
- (608) 340-1896
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1746381
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 4, 2025 | New notice | $250,000 | $242,034 | $7,966 | 13 | Oct 20, 2025 | sec.gov |
| Dec 16, 2024 | Amendment | $10,000,000 | $7,429,000 | $2,571,000 | 8 | Mar 30, 2023 | sec.gov |
| Oct 31, 2023 | New notice | $6,000,000 | $4,397,000 | $1,603,000 | 4 | Mar 30, 2023 | sec.gov |
| Oct 29, 2021 | New notice | $6,584,711 | $5,039,710 | $1,545,001 | 7 | Oct 15, 2021 | sec.gov |
| Oct 28, 2019 | New notice | $1,100,000 | $915,667 | $184,333 | 8 | Oct 18, 2019 | sec.gov |
| Jul 12, 2018 | New notice | $1,000,000 | $900,000 | $100,000 | 11 | Jun 29, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gilbert G Garcia | Director | |
| Mike G Bress | Executive Officer | |
| Lauren Tyra | Director | |
| Michael Partsch | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Nov 3, 2025 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Gregor Diagnostics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.